Skip to content
Home/Companies/Healthcare/ReViral
RE

ReViral

Healthcare·UK·Exited 2022·Held 7yr

ReViral is a healthcare company, headquartered in United Kingdom.

Entry
2015
Hold
7yr
Exit
2022
Est. EV
–

Who owns ReViral?

ReViral was owned by Andera Partners through BioDiscovery 4 (2013 vintage) from 2015 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Andera Partners
Investor
Andera Partners
BioDiscovery 4 · 2013 · VC

Key facts

HQUnited Kingdom
SectorHealthcare
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from BioDiscovery 4

Other portfolio companies in the same fund.

Inotrem
Active
HealthcareFrance
MedDay Pharmaceuticals
Exited 2021
HealthcareFrance· 2016
Verona Pharma
Exited 2017
HealthcareUK· 2016
Autonomic Technologies
Exited 2020
HealthcareUS· 2015
to
GAMAMABS
Active
HealthcareFrance· 2015
Sanifit
Exited 2021
HealthcareSpain· 2015
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings